Merit Medical Systems Inc (MMSI) - Total Assets
Based on the latest financial reports, Merit Medical Systems Inc (MMSI) holds total assets worth $2.72 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See MMSI total equity for net asset value and shareholders' equity analysis.
Merit Medical Systems Inc - Total Assets Trend (1989–2025)
This chart illustrates how Merit Medical Systems Inc's total assets have evolved over time, based on quarterly financial data.
Merit Medical Systems Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Merit Medical Systems Inc's total assets of $2.72 Billion consist of 38.7% current assets and 61.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 16.7% |
| Accounts Receivable | $223.61 Million | 8.3% |
| Inventory | $333.70 Million | 12.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $537.65 Million | 20.0% |
| Goodwill | $506.84 Million | 18.9% |
Asset Composition Trend (1989–2025)
This chart illustrates how Merit Medical Systems Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Merit Medical Systems Inc (MMSI) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Merit Medical Systems Inc's current assets represent 38.7% of total assets in 2025, a decrease from 50.0% in 1989.
- Cash Position: Cash and equivalents constituted 16.7% of total assets in 2025, up from 0.0% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 6.0% in 1989.
- Asset Diversification: The largest asset category is intangible assets at 20.0% of total assets.
Merit Medical Systems Inc Competitors by Total Assets
Key competitors of Merit Medical Systems Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151
|
China | CN¥4.77 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.06 Billion |
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.24 Billion |
|
IVF Hartmann Holding AG
SW:VBSN
|
Switzerland | CHF180.92 Million |
|
Dentium
KO:145720
|
Korea | ₩932.79 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$1.42 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
Merit Medical Systems Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.08 | 4.87 | 2.14 |
| Quick Ratio | 3.46 | 3.26 | 1.21 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $884.90 Million | $761.81 Million | $239.18 Million |
Merit Medical Systems Inc - Advanced Valuation Insights
This section examines the relationship between Merit Medical Systems Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.25 |
| Latest Market Cap to Assets Ratio | 1.36 |
| Asset Growth Rate (YoY) | 11.1% |
| Total Assets | $2.69 Billion |
| Market Capitalization | $3.66 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Merit Medical Systems Inc's assets above their book value (1.36x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Merit Medical Systems Inc's assets grew by 11.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Merit Medical Systems Inc (1989–2025)
The table below shows the annual total assets of Merit Medical Systems Inc from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $2.69 Billion | +11.05% |
| 2024-12-31 | $2.42 Billion | +4.02% |
| 2023-12-31 | $2.33 Billion | +39.74% |
| 2022-12-31 | $1.66 Billion | +0.95% |
| 2021-12-31 | $1.65 Billion | -0.97% |
| 2020-12-31 | $1.66 Billion | -5.29% |
| 2019-12-31 | $1.76 Billion | +8.48% |
| 2018-12-31 | $1.62 Billion | +45.71% |
| 2017-12-31 | $1.11 Billion | +17.93% |
| 2016-12-31 | $942.80 Million | +21.07% |
| 2015-12-31 | $778.73 Million | +4.22% |
| 2014-12-31 | $747.16 Million | +2.59% |
| 2013-12-31 | $728.28 Million | +3.26% |
| 2012-12-31 | $705.31 Million | +57.78% |
| 2011-12-31 | $447.02 Million | +20.84% |
| 2010-12-31 | $369.93 Million | +36.25% |
| 2009-12-31 | $271.51 Million | +17.14% |
| 2008-12-31 | $231.78 Million | +15.65% |
| 2007-12-31 | $200.42 Million | +9.72% |
| 2006-12-31 | $182.67 Million | +12.59% |
| 2005-12-31 | $162.25 Million | +15.99% |
| 2004-12-31 | $139.88 Million | +30.36% |
| 2003-12-31 | $107.30 Million | +37.03% |
| 2002-12-31 | $78.31 Million | +17.47% |
| 2001-12-31 | $66.66 Million | -6.70% |
| 2000-12-31 | $71.45 Million | -1.32% |
| 1999-12-31 | $72.40 Million | +42.80% |
| 1998-12-31 | $50.70 Million | +11.92% |
| 1997-12-31 | $45.30 Million | +8.63% |
| 1996-12-31 | $41.70 Million | +20.87% |
| 1995-12-31 | $34.50 Million | +27.78% |
| 1994-12-31 | $27.00 Million | +31.71% |
| 1993-12-31 | $20.50 Million | +25.00% |
| 1992-12-31 | $16.40 Million | +74.47% |
| 1991-12-31 | $9.40 Million | +154.05% |
| 1990-12-31 | $3.70 Million | +131.25% |
| 1989-12-31 | $1.60 Million | -- |
About Merit Medical Systems Inc
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires… Read more